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ABSTRACT
Background The USA and England have very different
health systems. Comparing hypertension care outcomes
in each country enables an evaluation of the
effectiveness of each system.
Method The English Longitudinal Study of Ageing and
the Health and Retirement Survey are used to compare
the prevalence of controlled, uncontrolled and
undiagnosed hypertension within the hypertensive
population (diagnosed or measured within the survey
data used) aged 50 years and above in the USA and in
England.
Results Controlled hypertension is more prevalent
within the hypertensive population in the USA (age
50–64: 0.53 (0.50 to 0.57) and age 65+: 0.51 (0.49 to
0.53)) than in England (age 50–64: 0.45 (0.42 to 0.48)
and age 65+: 0.42 (0.40 to 0.45)). This difference is
driven by lower undiagnosed hypertension in the USA
(age 50–64: 0.18 (0.15–0.21) and age 65+: 0.13 (0.12
to 0.14)) relative to England (age 50–64: 0.26 (0.24 to
0.29) and age 65+: 0.22 (0.20 to 0.24)). The
prevalence of uncontrolled hypertension within the
hypertensive population is very similar in the USA (age
50–64: 0.29 (0.26 to 0.32) and age 65+: 0.36 (0.34 to
0.38)) and England (age 50–64: 0.29 (0.26 to 0.32)
and age 65+: 0.36 (0.34 to 0.39)). Hypertension care
outcomes are comparable across US insurance
categories. In both countries, undiagnosed hypertension
is positively correlated with wealth (ages 50–64).
Uncontrolled hypertension declines with rising wealth in
the USA.
Conclusions Different diagnostic practices are likely to
drive the cross-country differences in undiagnosed
hypertension. US government health systems perform at
least as well as private healthcare and are more
equitable in the distribution of care outcomes. Higher
undiagnosed hypertension among the afﬂuent may
reﬂect less frequent medical contact.
INTRODUCTION
Hypertension is a major risk factor for cardiovascu-
lar disease.1 Recent increases in the hypertensive
population are attributed to population ageing,
population growth and the rise of unhealthy life-
style choices related to diet and sedentary living.2
In developed countries, hypertension is most preva-
lent at the middle and older ages and is predomin-
antly systolic in nature.3 Hypertension increases
with age because of increases in vascular resistance
and arterial stiffness4 with aspects of culture and
environment being important contributory factors.5
Control of hypertension, through healthy lifestyle
choices and, where necessary, medical intervention,
is recognised as a key way to mitigate the health-
care challenges associated with population
ageing.6–9
In this paper, we compare hypertension health-
care outcomes among older people (aged 50 years
and above) in the USA and England. We focus on
the total hypertensive population (either diagnosed
with hypertension or measured as hypertensive),
assessing whether levels of controlled, uncontrolled
and undiagnosed hypertension among older people
differ in the USA and England. We also stratify our
analysis by wealth and (US) health insurance.
Control of hypertension provides interesting
insights into the effectiveness of a particular health-
care system. Hypertension is usually asymptomatic
and so identiﬁcation requires effective screening,
but the condition is relatively easy to treat and
interventions are cheaper than dealing with subse-
quent heath problems.1 Our overall concern is to
compare outcomes across different healthcare
systems and populations served by them.
The provision of healthcare is very different in the
USA and England. In England, the National Health
Service provides a publicly funded healthcare system
with a comprehensive range of health services, most
of which are free at the point of use. In contrast, the
USA lacks universal health coverage and most health-
care is provided through private organisations. There
are two main Government health insurance schemes.
Medicaid provides health insurance coverage to the
poor, disabled and those with speciﬁc health pro-
blems. Medicare covers all those aged over 65 and
who are US citizens or have been permanent resi-
dents in the USA for at least 5 years.
The guidelines around the diagnosis and treatment
of hypertension are more aggressive in the USA than
in England.10 11 While both countries use a clinical
threshold of 140/90 mmHg, the USA also identiﬁes
a prehypertensive group (120–139 mmHg) who are
encouraged to make lifestyle changes to reduce blood
pressure.11 In England (but not the USA), a formal
cardiovascular risk assessment precedes hypertension
treatment. In the absence of cardiovascular risks or
existing organ damage, treatment is then offered to
those with measured blood pressure greater than
160/110 mmHg. The Quality Outcomes Framework
in England uses an auditing blood pressure threshold
of 150/90 mmHg, rather than 140/90 mmHg as in
the National Institute for Care Excellence clinical
guidelines. Higher levels of self-reported doctor-
diagnosed hypertension in older adults (age 55–64)
in the USA (42%) compared to England (34%)12 and
greater use of medication to control hypertension13 14
in the USA reﬂect the different guidelines described.
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The existing research on hypertension care in the USA and
England focuses on management of the condition in the popula-
tion diagnosed with hypertension. It ﬁnds no cross-country dif-
ference in the levels of control of hypertension to clinical
targets between the ages of 50 and 65 but greater control in the
USA over the age of 65.14 We extend this research in a number
of important areas, providing a fuller account of the effective-
ness of each healthcare system in managing the condition. We
include undiagnosed hypertension in our analysis rather than
focusing only on the management of known cases of high blood
pressure. Public health systems have a responsibility to treat
known cases of hypertension as well as to identify individuals
with high blood pressure, especially given the asymptomatic
nature of the condition. Thus, comparison of undiagnosed
hypertension in the USA and England is an essential aspect of
any cross-national evaluation of hypertension management. We
also consider differences in hypertension care outcomes among
persons aged 50–64 years with different forms of US health
insurance, rather than simply treating this age group as being
covered by a single ‘market-based’ system.14 This distinction is
particularly valuable because it includes those individuals who
hold no health insurance, an important concern of healthcare
systems dominated by the private sector.
METHODS
Data
We use wave four of the English Longitudinal Study of Ageing
(ELSA)15 and wave nine of the Health and Retirement Survey
(HRS),16 representative samples of the population aged over 50
in England and the USA in 2008/2009. We include only those
previously diagnosed with or being treated for hypertension or
who were measured as hypertensive; all our results (unless
otherwise stated) apply to this hypertensive population. Our
sample sizes are 4586 in HRS and 4307 in ELSA. Table 1 pro-
vides the descriptive statistics.
Variables
HRS and ELSA are harmonised with a comparable set of data
on the health and circumstances of the older population. We
create a hypertension care variable with three outcomes:
Hypertension controlled—individuals diagnosed with hyper-
tension in the past or receiving treatment for the condition
who were normotensive in the survey
Hypertension uncontrolled—individuals diagnosed with
hypertension in the past or receiving treatment for the condi-
tion who were hypertensive in the survey
Hypertension undiagnosed—individuals never diagnosed with
hypertension in the past and not receiving treatment for the
condition who were hypertensive in the survey
Throughout this paper, we use a threshold of systolic blood
pressure over 140 mm Hg or a diastolic blood pressure over
90 mm Hg to indicate measured high blood pressure reﬂecting
clinical guidelines. In the HRS and ELSA, three blood pressure
measurements were taken 60 s apart. The average of at least two
of these measures is used in the analysis reported here. Blood
pressure was measured using an Omron HEM-780 blood pres-
sure monitor in the HRS and an Omron HEM-907 blood pres-
sure monitor in ELSA. In HRS and ELSA, previous diagnosis
and hypertension treatment are self-reported. We include a
number of other control variables in our model that are known
to be associated with hypertension (age, sex, body mass index
(BMI), ethnicity (White, Non-White England, Non-White US),
wealth quintiles (total net wealth of household (US) or beneﬁt
unit (England)) and US insurance group (no insurance, private
insurance, government insurance).
Model
We ﬁt multinomial logistic regression models to predict hyper-
tension healthcare outcome taking hypertension controlled as
our reference category. We ﬁt three sets of models.
1. Base model—country, age, sex, BMI, ethnicity (White,
England Non-White, US Non-White)
2. Health insurance model—country and insurance status
(England, US private insurance, US government insurance,
US no insurance), age, sex, ethnicity, BMI, wealth
3. Wealth inequality model—age, sex, BMI, ethnicity and
wealth (models ﬁtted for the USA and England separately)
We ﬁt all models in Stata (SE/12.1 for windows) using
maximum likelihood estimation and use appropriate survey
weights to account for sample selection and non-response. We
ﬁt separate models for the population aged under 65 and the
population aged 65 or over, reﬂecting the very different health
insurance systems in the USA for each age group.
RESULTS
For the full older population in the HRS and ELSA samples, the
mean systolic blood pressure is higher in England (133 mm Hg)
compared to the USA (131 mm Hg) (p<0.0001), a difference
that holds for women (USA: 132 mm Hg, England 130 mm Hg
(p<0.0001)), but not men (USA: 134 mm Hg, England
134 mm Hg (p=0.94)). Mean diastolic blood pressure is lower
in England (74 mm Hg) relative to the USA (79 mm Hg)
(p<0.0001) with similar ﬁndings by sex. The analysis presented
from here relates to the population either previously treated/
diagnosed with hypertension or measured with high blood pres-
sure. In the USA, this comprises 59% of the population aged
50–64 and 74% of the population aged 65+; in England, this
comprises 45% of the population aged 50–64 and 68% of the
population aged 65+. These differences between countries for
each age group are statistically signiﬁcant (p<0.0001) and
driven by higher levels of diagnosis/treatment in the USA.
Figure 1 summarises these differences, with the proportion of
the total hypertensive population with uncontrolled hyperten-
sion comparable in each country.
We now consider whether the cross-country differences in
hypertension care outcomes (ﬁgure 1) hold after controlling for
age, sex, BMI and ethnicity. We then examine if there are
further differences in hypertension care outcomes across US
insurance groups and how these compare to England where
there is universal access to the National Health Service.
Taking the base model ﬁrst, the most striking difference in
ﬁgure 2A is the lower predicted probability of having undiag-
nosed hypertension in the USA compared to England for both
the 50–64 and 65+ age groups. Figure 2A reveals higher
control of hypertension in the USA compared to England (at
both age groups) whilst levels of uncontrolled hypertension are
very similar in the USA and England at each age group.
Interestingly, if we set the threshold for measured high blood
pressure at the auditing level in the English Quality Outcomes
Framework (150/90 mm Hg), then cross-national differences in
care outcomes are not signiﬁcant except for persisting (but atte-
nuated) lower levels of undiagnosed hypertension in the USA at
the very oldest ages (results not shown).
The insurance model adds detail to the base model by subdiv-
iding the USA into groups of ‘private insurance’, ‘Government
insurance’ and ‘no insurance’ (see table 2 and ﬁgure 2B.).
Striking results are the very low level of undiagnosed
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hypertension among those with government insurance (50–64)
and the comparability of hypertension healthcare outcomes for
those over the age of 65 in the USA regardless of the insurance
category. Unsurprisingly, those with no insurance have the worst
care outcomes in the USA although the relative risk ratios are
not signiﬁcantly different to the private group (reference cat-
egory) indicating no difference in the relative risk of switching
between categories of hypertension care conditional on being in
the ‘US no insurance group’ compared to the ‘US private insur-
ance group’. However, it seems likely that the small sample size
of the population with no insurance (see table 1) lacks sufﬁcient
power for differences to be distinguished. Levels of undiagnosed
hypertension are signiﬁcantly higher in England compared to
the US group with private insurance, but model probabilities of
uncontrolled hypertension are comparable in England and for
those in the US with private insurance.
The wealth models test whether there are wealth gradients in
hypertension healthcare outcomes in the USA and England
separately.i There is little evidence of a wealth gradient in
uncontrolled hypertension in England, but an indication of
lower risks of uncontrolled hypertension with increasing wealth
in the USA (see table 3). For the 50–64 age group in England
and the USA, there is a suggestion of increases in the probability
of undiagnosed hypertension with wealth. Interestingly, the
wealth gradient of undiagnosed hypertension in England
disappears after including a variable indicating whether an indi-
vidual had a blood pressure test in the year prior to the inter-
view (results not shown). We do not ﬁnd any evidence for a
wealth gradient in undiagnosed hypertension for the 65+ age
group in either country.
Table 1 Summary statistics on variables in the HRS and ELSA samples
England USA
N Per cent 95% CI N Per cent 95% CI
Hypertension care outcome
Hypertension controlled 1849 44 42 to 45 2381 51 49 to 53
Hypertension uncontrolled 1428 33 31 to 34 1563 33 32 to 35
Hypertension undiagnosed 1030 24 22 to 25 642 16 14 to 17
Gender
Males 2012 47 46 to 49 1887 47 45 to 49
Females 2325 53 51 to 54 2650 53 51 to 55
Age†
50–54 272 8 7 to 9 148 2 1 to 3
55–59 612 18 16 to 19 548 22 21 to 24
60–64 900 17 16 to 18 558 20 18 to 22
65–69 682 13 12 to 14 875 16 15 to 17
70–74 764 14 13 to 15 874 13 11 to 13
75–79 527 12 11 to 14 705 11 10 to 12
80–84 326 9 8 to 11 441 9 8 to 10
85 254 8 7 to 10 388 7 7 to 8
BMI
Underweight 21 0.01 0.003 to 0.009 47 0.009 0.006 to 0.012
Normal 817 20 18 to 21 1121 24 22 to 25
Overweight 1716 42 40 to 44 1730 39 37 to 41
Obese 1570 38 36 to 40 1591 37 35 to 39
Ethnicity
White 4202 97 96 to 98 3592 84 82 to 85
Non White 102 3 2 to 4 945 16 15 to 18
Wealth quintiles
Least well off 767 21 20 to 23 894 19 18 to 21
Second least well off 886 22 20 to 23 1015 22 21 to 24
Middle wealth quintile 857 19 18 to 21 916 20 18 to 21
Second most well off 890 20 19 to 22 876 19 18 to 21
Most well off 846 17 16 to 19 836 19 18 to 21
Health Insurance
Private insurance NA 2558 63 61 to 64
Government insurance NA 1778 32 30 to 34
No insurance NA 190 6 5 to 7
Blood pressure test
Took a test in the last year 3883 88 87 to 89 NA
Did not take a test in the last year 500 12 11 to 13 NA
All percentages reported in this table are weighted using appropriate survey weights.
BMI, body mass index; ELSA, English Longitudinal Study of Ageing; HRS, Health and Retirement Survey; NA, not applicable.
iWe obtain the same conclusions if we ﬁt a single model with a
country*wealth interaction (results not shown).
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DISCUSSION
The results above reveal four key ﬁndings relating to the popula-
tion with hypertension (either previously diagnosed or mea-
sured within the HRS/ELSA surveys). First, there are higher
levels of undiagnosed hypertension in England relative to the
USA with comparable probabilities of uncontrolled hypertension
in each country. Second, there is no evidence to suggest that
older people in the USA with private health insurance receive
better hypertension care compared to those who hold govern-
ment insurance, including at the 50–64 age group, where there
is a suggestion that care outcomes are worst for those lacking
any health insurance. Third, in each country, there are higher
levels of undiagnosed hypertension among the most afﬂuent
than among the poorest. Finally, the US healthcare system is less
equitable than that in England in terms of uncontrolled hyper-
tension, which becomes less prevalent with increasing wealth.
The greater extent of undiagnosed hypertension (among
those with hypertension) in England relative to the USA may
stem from the different procedures in each healthcare system for
diagnosing and treating hypertension. In particular, the Quality
Outcomes Framework in England may have incentivised
primary care practices to treat to a blood pressure threshold of
150/90 mm Hg, rather than 140/90 mm Hg as in the National
Institute for Care Excellence clinical guidelines. Evidence on the
beneﬁts of medication for those with borderline hypertension
(140–150 mm Hg) is mixed,17 particularly at the very oldest
ages (80+),7 18 and further research is required to determine
whether the lower levels of undiagnosed hypertension in the
USA confer cardiovascular advantages.
In the USA, the private healthcare system is not more
effective than government healthcare systems in managing
hypertension among the elderly. The only signiﬁcant differ-
ence between care outcomes is the lower level of undiagnosed
hypertension for those between 50 and 64 years of age with
government insurance. Those holding government insurance
at these ages are typically either living in poverty or have
poor health qualifying them for Medicaid. We argue that
those with Medicaid are likely to have greater contact with
health professionals as a result of their health status, confer-
ring increased opportunity for hypertension diagnosis. Those
with no health insurance, unsurprisingly, have the worst
hypertension healthcare outcomes in the USA. Although the
poorer care outcome for those with no insurance failed to
achieve statistical signiﬁcance, it seems likely that the small
sample size (192) and a lack of power is most likely respon-
sible for this lack of signiﬁcance.
The increasing risk of undiagnosed hypertension with wealth in
the USA and England is an interesting ﬁnding. We argue that a key
driver of this gradient in undiagnosed hypertension is the fre-
quency with which poorer individuals see health professionals.
Figure 2 (A) Model probabilities of hypertension care outcomes in the USA and England in the base model (B). Model probabilities of
hypertension care outcomes in the USA and England in the insurance model. The health insurance model includes explanatory variables of age, sex,
wealth, ethnicity (white, US Non-White, England Non-White), BMI and insurance status (US private insurance, US Government insurance, US no
insurance and England (NHS)). BMI, body mass index; NHS, National Health Service.
Figure 1 (A) Proportions in each hypertension category (hypertensive controlled, hypertensive uncontrolled and hypertensive undiagnosed) in
England and the USA (males) (B). Proportions in each hypertension category (hypertensive controlled, hypertensive uncontrolled and hypertensive
undiagnosed) in England and the USA (females).
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Research suggests poorer people are most likely to visit their
doctor (although this gradient loses statistical signiﬁcant or changes
direction when health need is taken into account),19 offering a
greater opportunity for blood pressure checks. Support for our
hypothesis is provided by including a variable indicating whether a
person had their blood pressure measured in the year prior to their
survey interview. This removes the wealth gradient in undiagnosed
hypertension in England (results not shown). Undiagnosed hyper-
tension is not related to wealth at the older age group (65+), pos-
sibly reﬂecting the introduction of routine health tests at age 65.
Levels of uncontrolled hypertension are more evenly distribu-
ted by wealth in universal government administered healthcare
systems than in private healthcare systems. We see no evidence
of a gradient in uncontrolled hypertension in England under the
NHS. In the USA, the risks of uncontrolled hypertension fall
with wealth for those aged 50–64, where private health insur-
ance dominates, and while a similar gradient exists over the age
of 65, where there is universal health coverage (Medicare), it is
less prominent. Private healthcare systems appear to disadvan-
tage poorer people who may be unable to afford the costs of
healthcare and have higher levels of uncontrolled hypertension
relative to the richest as a result, a ﬁnding noted elsewhere.14
A key strength of this study is that our ﬁndings are based on
representative samples of the community-dwelling population at
least 50 years of age in the USA and England. However, there are
some limitations to this work. First, our data are subject to issues
of non-response. Although we deal with any resulting bias
through the use of survey weights and refreshment samples, we
cannot be certain that we have accounted for all the differences
between those who participated in the survey and those who
dropped out. Second, we attribute differences in healthcare out-
comes to the provider of healthcare in each country (government
and private) but acknowledge that a number of other differences
might be involved. For example, compared to England, the USA
has a more specialised health service (higher ratio of specialists to
generalists), spends more of its gross domestic product (GDP) on
healthcare, and has a multitude of investors in healthcare (com-
pared to a single payer in England), complicating chains of
accountability.14 Finally, we accept that our measurement thresh-
old for hypertension of 140/90 mm Hg on average of at least two
measurements during a single clinical visit differs slightly from
Table 2 RRR* from the base and health insurance models
Under 65‡ Over 65‡
RRR SE p>z RRR SE p>z
Uncontrolled hypertension†
Base model§
England 1 1
USA 0.83 0.10 0.11 0.83 0.06 0.02
Insurance model¶
US Private insurance 1 1
US Government insurance 0.96 0.20 0.86 1.02 0.09 0.80
US no insurance 1.54 0.38 0.07 NA NA NA
England 1.25 0.15 0.07 1.21 0.10 0.03
Undiagnosed hypertension†
Base model§
England 1 1
USA 0.57 0.07 <0.0001 0.50 0.05 <0.0001
Insurance model¶
US Private insurance 1 1
US Government insurance 0.32 0.13 0.01 1.11 0.15 0.45
US no insurance 1.35 0.37 0.27 NA NA NA
England 1.66 0.22 <0.0001 2.14 0.24 <0.0001
*RRR are the exponential of the coefficients in the multinomial logistic regression.
They give the relative risk of switching between explanatory variable categories on
being in a category of the response variable compared to the reference category. For
example, in the insurance model (under the age of 65), the relative risk ratio of
switching from US private insurance to US Government insurance is 0.32 for being in
the undiagnosed hypertension category versus the controlled hypertension category
(reference). In other words, the expected risk of staying in the undiagnosed
hypertension category (as opposed to the reference of controlled hypertension) is
lower for respondents with US Government insurance than with US Private insurance.
†The reference category is controlled hypertension.
‡Models are fitted for the under 65 and the 65 and over age groups separately.
§The base model includes explanatory variables of age, sex, country, ethnicity (white,
US Non-White, England Non-White), BMI.
¶The health insurance model includes explanatory variables of age, sex, wealth,
ethnicity (white, US Non-White, England Non-White), BMI and insurance status
(US private insurance, US Government insurance, US no insurance and England
(NHS)).
BMI, body mass index; NA, not applicable; NHS, National Health Service; RRR,
relative risk ratios.
Table 3 RRR* from the USA and England wealth models
Under 65 Over 65
RRR SE p>z RRR SE p>z
England wealth model†
Uncontrolled hypertension‡
Wealth model (England)
1 Poorest quintile 1 1
2 0.87 0.21 0.56 1.27 0.25 0.23
3 1.00 0.25 1.00 1.15 0.22 0.47
4 1.56 0.36 0.05 1.25 0.25 0.26
5 Richest quintile 1.08 0.25 0.76 1.29 0.26 0.20
Undiagnosed hypertension‡
Wealth model (England)
1 Poorest quintile 1 1
2 1.19 0.29 0.47 0.89 0.19 0.58
3 1.46 0.37 0.13 0.92 0.20 0.71
4 1.68 0.41 0.03 0.96 0.21 0.84
5 Richest quintile 1.58 0.38 0.06 1.36 0.29 0.15
US wealth model†
Uncontrolled hypertension‡
Wealth model (USA)
1 Poorest quintile 1 1
2 1.07 0.23 0.75 0.98 0.14 0.91
3 0.80 0.19 0.34 1.00 0.14 0.98
4 0.65 0.17 0.10 0.73 0.11 0.03
5 Richest quintile 0.57 0.15 0.04 0.78 0.12 0.10
Undiagnosed hypertension‡
Wealth model (USA)
1 Poorest quintile 1 1
2 1.58 0.48 0.13 1.07 0.23 0.77
3 1.46 0.47 0.24 1.21 0.26 0.39
4 2.26 0.72 0.01 1.24 0.26 0.30
5 Richest quintile 2.43 0.77 0.01 1.07 0.23 0.76
*The relative risk ratios are the exponential of the coefficients in the multinomial
logistic regression. They give the relative risk of switching between explanatory
variable categories on being in a category of the response variable compared to the
reference category. For example, in the wealth model (under the age of 65), the
relative risk ratio of switching from the poorest quintile to the richest quintile is 0.57
for being in the uncontrolled hypertension category versus the controlled hypertension
category (reference). In other words, the expected risk of staying in the uncontrolled
hypertension category (as opposed to the reference of controlled hypertension) is
lower for the richest individuals compared to the poorest individuals.
†Models control for age, sex, wealth, ethnicity (white, Non-White), BMI and are fitted
separately for each country and for each age groups (50–64 and 65+).
‡The reference category is controlled hypertension.
BMI, body mass index; RRR, relative risk ratios.
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the national guidelines in the USA and England,10 11 which
require demonstration of high blood pressure on two separate
clinical occasions. As a result, our analysis may overestimate
levels of undiagnosed hypertension. Nevertheless, given that we
used common study methods and deﬁnitions in the USA and
England, our ﬁndings on country-speciﬁc differences in hyper-
tension care outcomes should still hold.
In conclusion, our results on hypertension care outcomes for
the hypertensive population (diagnosed or measured within the
HRS/ELSA survey) reveal higher levels of undiagnosed hyper-
tension in England compared to the USA, a result that may stem
from different guidelines around the treatment of the condition.
Importantly, levels of uncontrolled hypertension are similar in
each country, indicating that once the condition is identiﬁed, the
performance of the USA and English health systems is compar-
able. The US health system appears less equitable than that in
England in terms of uncontrolled hypertension, perhaps as a
result of the costs of healthcare in the USA which poorer indivi-
duals are less able to meet. For older people in the USA, there
appears to be no advantage in holding private health insurance
compared to Government health insurance in terms of the
hypertension care received. Interestingly, in both countries, the
levels of undiagnosed hypertension are greatest for the most
afﬂuent, a result that may reﬂect less frequent tests of blood
pressure among the most wealthy.
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